Direct inhibitory effect of hypercalcemia on renal actions of parathyroid hormone
- PMID: 4359938
- PMCID: PMC333052
- DOI: 10.1172/JCI107610
Direct inhibitory effect of hypercalcemia on renal actions of parathyroid hormone
Abstract
The effects of calcium on the renal actions of parathyroid hormone (PTH) were studied in vivo and in vitro. In parathyroidectomized rats, variable levels of blood calcium concentration were induced by intravenous infusion of calcium. The renal responses to the injected PTH, i.e. phosphate and cyclic AMP excretion, were compared in these animals. After PTH injection, the increases of both phosphate and cyclic AMP excretion were less in the calcium-infused animals than in the control group without calcium infusion. There was an inverse correlation between the renal responses to PTH and plasma calcium concentration of 4.2-13.5 mg/100 ml. But calcium had no effect on phosphate excretion induced by infusion of dibutyryl cyclic AMP. In the in vitro experiments, the increase of cyclic AMP concentration in response to PTH was less in renal cortical slices taken from the calcium-infused animals than in ones from the control group without calcium infusion. Calcium also inhibited the activation of renal cortical adenylate cyclase in response to PTH, but calcium had no effect on phosphodiesterase. The data indicate that calcium directly inhibits renal actions of PTH both in vivo and in vitro. Such inhibitory mechanism is probably at or before the step of PTH-dependent cyclic AMP generation in the kidney.
Similar articles
-
Impaired renal response to parathyroid hormone in potassium depletion.Am J Physiol. 1975 Jan;228(1):179-83. doi: 10.1152/ajplegacy.1975.228.1.179. Am J Physiol. 1975. PMID: 167590
-
Renal adenylate cyclase and the interrelationship between parathyroid hormone and vitamin D in the regulation of urinary phosphate and adenosine cyclic 3',5'-monophosphate excretion.J Clin Invest. 1976 Mar;57(3):559-68. doi: 10.1172/JCI108311. J Clin Invest. 1976. PMID: 175088 Free PMC article.
-
Pathogenic role of cyclic AMP in the impairment of urinary concentrating ability in acute hypercalcemia.J Clin Invest. 1974 Nov;54(5):1049-55. doi: 10.1172/JCI107848. J Clin Invest. 1974. PMID: 4371361 Free PMC article.
-
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.Dan Med Bull. 2008 Nov;55(4):186-210. Dan Med Bull. 2008. PMID: 19232159 Review.
-
Nephrogenous cyclic AMP, adenylate cyclase-stimulating activity, and the humoral hypercalcemia of malignancy.Recent Prog Horm Res. 1986;42:705-50. doi: 10.1016/b978-0-12-571142-5.50021-5. Recent Prog Horm Res. 1986. PMID: 3016837 Review. No abstract available.
Cited by
-
Rapid development of renal resistance to low doses of synthetic bovine parathyroid hormone fragment 1-34. Dissociation of urinary cyclic adenosine monophosphate, phosphaturic, and calciuric responses.J Clin Invest. 1983 Sep;72(3):1106-13. doi: 10.1172/JCI111035. J Clin Invest. 1983. PMID: 6309905 Free PMC article.
-
Inhibitory effects of hypermagnesemia on the renal action of parathyroid hormone.J Clin Invest. 1976 Nov;58(5):1273-9. doi: 10.1172/JCI108582. J Clin Invest. 1976. PMID: 186487 Free PMC article.
-
Inhibition of carbonic anhydrase by parathyroid hormone and cyclic AMP in rat renal cortex in vitro.J Clin Invest. 1975 Jan;55(1):149-56. doi: 10.1172/JCI107905. J Clin Invest. 1975. PMID: 233968 Free PMC article.
-
Familial hypocalciuric hypercalcaemia--familial benign hypercalcaemia: a review.Postgrad Med J. 1987 Oct;63(744):835-40. doi: 10.1136/pgmj.63.744.835. Postgrad Med J. 1987. PMID: 3328847 Free PMC article. Review. No abstract available.
-
Inhibition of renal adenylate cyclase by plasma from uremic patients.J Endocrinol Invest. 1982 Sep-Oct;5(5):303-9. doi: 10.1007/BF03350518. J Endocrinol Invest. 1982. PMID: 7153474
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources